Experience from a randomized controlled trial with Impella 2.5 versus IABP in STEMI patients with cardiogenic pre-shock. Lessons learned from the IMPRESS in STEMI trial

D. M. Ouweneel, A. E. Engstrom, K. D. Sjauw, A. Hirsch, J. M. Hill, B. Gockel, V. Tuseth, R. J. van der Schaaf, J. P. S. Henriques

Research output: Contribution to journalComment/Letter to the editorAcademic

67 Citations (Scopus)
Original languageEnglish
Pages (from-to)894-896
JournalInternational journal of cardiology
Volume202
DOIs
Publication statusPublished - 2016

Cite this